4-(4-Bromophenethyl)morpholine
≥95%
- Product Code: 46320
CAS:
736991-39-2
| Molecular Weight: | 270.17 g./mol | Molecular Formula: | C₁₂H₁₆BrNO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11855960 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Researchers often employ it to develop compounds that interact with specific receptors in the brain, such as serotonin or dopamine receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, its structural features make it a valuable building block for creating novel drug candidates with potential therapeutic effects. Its application extends to the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of new drugs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿4,077.00 |
+
-
|
| 1.000 | 10-20 days | ฿10,206.00 |
+
-
|
| 5.000 | 10-20 days | ฿29,088.00 |
+
-
|
4-(4-Bromophenethyl)morpholine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Researchers often employ it to develop compounds that interact with specific receptors in the brain, such as serotonin or dopamine receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, its structural features make it a valuable building block for creating novel drug candidates with potential therapeutic effects. Its application extends to the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of new drugs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :